We were originally incorporated in the state of Minnesota in December 2002 and reincorporated in the state of Delaware in July 2004. In 2017, we changed our name from EnteroMedics Inc. to ReShape Lifesciences Inc.
Our principal executive offices are located at 1001 Calle Amanecer, San Clemente, CA 92673, and our telephone number is (949) 429-6680.
- The Company completed its initial public offering for the OTC markets on November 15, 2007
- The Company listed on The Nasdaq Capital Market on June 16, 2021
ReShape Lifesciences trades on NASDAQ under the symbol RSLS.
The Company operates with a December 31 fiscal year end.
Annual Reports, Form 10-Ks, Form 10-Qs and other reports are posted to this website as soon as they are filed with the SEC.
Contact a licensed stockbroker to purchase shares in our company.
The Company is a medical technology company focused on the design, development and communication of transformative technology to treat obesity and metabolic diseases.
The Company has not historically paid dividends.
Equiniti (formerly Wells Fargo Shareowner Services)
A transfer agent is a trust company, bank or similar financial institution assigned by a corporation to maintain records of investors and account balances.
BDO (Costa Mesa, CA)
ReShape is incorporated in Delaware